Oblita Therapeutics (SRL)
Active
VAT
BE 0832.102.424
Address
Oostmallebaan 87
2980
Zoersel
Established
20-12-2010
Principal activity
Research and experimental development on biotechnology
Crisis resilience of Oblita Therapeutics
Which companies are best armed against current economic trends and the energy crisis?
Read moreFinancial data of Oblita Therapeutics
2022
|
2021
|
2020
|
2019
|
||||
|---|---|---|---|---|---|---|---|
| Profit/Loss | €20,628 | 210% |
-€18,828 | -112% |
-€8,861 | 17% |
-€10,727 |
| Equity | €132,158 | 128% |
€57,967 | -24% |
€76,092 | > 1.000% |
-€3,776 |
| Gross margin | €22,237 | 234% |
-€16,602 | -105% |
-€8,106 | -19% |
-€6,786 |
Publications in the Belgian Official Journal for Oblita Therapeutics
Frequently asked questions
What is the VAT number of Oblita Therapeutics?
The VAT number of Oblita Therapeutics is BE0832102424.
When was Oblita Therapeutics founded?
Oblita Therapeutics was founded on 20-12-2010.
What is the address of Oblita Therapeutics?
The current registered office of Oblita Therapeutics is located at Oostmallebaan 87, 2980 Zoersel.
When was the last time Oblita Therapeutics filed their annual financial statements?
The most recent financial statements of Oblita Therapeutics were filed on 01-09-2023. You can view them here.
How many employees does Oblita Therapeutics have?
There are currently no employees working at Oblita Therapeutics or no workforce information is available.
What is the annual turnover of Oblita Therapeutics?
At the time of its most recent financial statements, Oblita Therapeutics did not publish any turnover figures. Oblita Therapeutics reported a gross margin of €22,237.27.
